News

STAT7m
For many Duchenne families, halt to gene therapy is heartbreak upon heartbreak
As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...
Lassen News7h
HHS, FDA and USDA address the health risks of ultra-processed foods
Under the leadership of the U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. and the U.S.
Law8h
What FDA and USDA's New Pursuit of 'Ultra-Processed Foods' Definition Means for Emerging Litigation
But a recent move from the U.S. Food and Drug Administration and U.S. Department of Agriculture may end up giving the term ...
Fierce Pharma10h
FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report
Sarepta would need to conduct new analyses to validate the safety of Elevidys—which has had U.S. shipments paused by the ...
Quality Assurance & Food Safety11h
FDA, USDA to Define Ultra-Processed Foods
The two agencies announced a joint request for information to gather data to establish a federally recognized, uniform ...
GoodRx on MSN12h
New medications coming soon: Here’s what’s been FDA approved in 2025 so far
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...
Becker's Spine Review14h
10 spine FDA nods
From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.
Verastem Oncology gets FDA fast track status for cancer drug
Verastem Oncology ( NASDAQ: VSTM) said that the U.S. FDA has granted fast track designation to its experimental drug ...
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
The FDA’s Newest Approval Could Have a Major Impact on Your Favorite Foods
Move over, artificial food colors, the FDA just approved gardenia (genipin) blue, a plant‑derived dye to shake up drinks and ...
Fierce Biotech22h
'Crossing fingers': Boehringer awaits key FDA decisions to spearhead 'maturing' pipeline
It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer ...
US FDA extends review of GSK's blood cancer drug
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.